Tvardi Therapeutics Reports Results for Quarter Ended June 30, 2026

What Happened
Tvardi Therapeutics, Inc. announced its financial results and business highlights for the fiscal quarter ended June 30, 2026 in a press release dated August 14, 2026. The company furnished the press release as Exhibit 99.1 to its Form 8-K (Item 2.02).

Key Details

• Press release announcing quarterly financial results and business highlights issued on August 14, 2026.
• Covers the fiscal quarter ended June 30, 2026.
• Press release is attached to the Form 8-K as Exhibit 99.1.
• The filing includes an Inline XBRL cover page (Exhibit 104) for interactive data.

Why It Matters
This 8-K furnishes Tvardi’s latest quarterly results and business updates, which are material for investors assessing the company’s recent financial performance and near-term prospects. Retail investors should review the attached press release (Exhibit 99.1) to see specific figures for revenue, earnings (or losses), and any operational or clinical highlights that could affect the company’s outlook.